Sector677 stocks
Health Care: Insider Trades, Congress and Prices
Drug makers, biotech labs, medical device makers, hospitals and health insurers. In the past 12 months insiders at these companies reported 1848 open-market purchases worth $3.21B and 6813 sales worth $29.4B.
−4.6%Average change, 3 months
1848Insider buys, 12 months
6813Insider sales, 12 months
404Congress trades, 12 months
Health Care heatmap
IRIXn/an/an/aIRIDEX CORPUTHRn/an/an/aUNITED THERAPEUTICS CorpACOGn/an/an/aAlpha Cognition Inc.PCSAn/an/an/aProcessa Pharmaceuticals, Inc.NTRAn/an/an/aNatera, Inc.LQDA+1.1%−12.5%+200.1%Liquidia CorpADPTn/an/an/aAdaptive Biotechnologies CorpTWST+29.3%+84.2%+488.4%Twist Bioscience CorpMPLTn/an/an/aMapLight Therapeutics, Inc.INM+0.7%−13.4%n/aInMed Pharmaceuticals Inc.BCDAn/an/an/aBioCardia, Inc.ARTVn/an/an/aArtiva Biotherapeutics, Inc.BSX−8.7%+1.0%−54.2%BOSTON SCIENTIFIC CORPBOLDn/an/an/aBoundless Bio, Inc.DYNn/an/an/aDyne Therapeutics, Inc.STLNn/an/an/aStarling Oncology, Inc.CSTLn/an/an/aCASTLE BIOSCIENCES INCNTHI−29.4%−27.7%−67.2%NEONC TECHNOLOGIES HOLDINGS, INC.ABT−9.9%+7.6%−24.2%ABBOTT LABORATORIESCYTK−8.9%−20.1%+19.4%CYTOKINETICS INCJNJ+2.0%+6.5%+43.8%JOHNSON & JOHNSONKRRO−17.6%−29.9%n/aKorro Bio, Inc.SLGL−3.3%−9.0%+129.0%Sol-Gel Technologies Ltd.ISRGn/a−2.4%−8.1%INTUITIVE SURGICAL INCPHVSn/an/an/aPharvaris N.V.WGSn/an/an/aGeneDx Holdings Corp.PRTA−6.5%−10.9%+8.1%PROTHENA CORP PUBLIC LTD COFTHn/a+22.4%n/aFaeth Therapeutics, Inc.ANIXn/an/an/aAnixa Biosciences IncPACS+1.8%+2.8%n/aPACS Group, Inc.ROIV−13.7%+5.1%+124.0%Roivant Sciences Ltd.GRCEn/an/an/aGrace Therapeutics, Inc.OFIX+1.4%n/a−35.4%Orthofix Medical Inc.VRTX−2.9%+7.1%+34.4%VERTEX PHARMACEUTICALS INC / MAKYMRn/an/an/aKymera Therapeutics, Inc.LLYn/an/an/aELI LILLY & CoTVTXn/an/an/aTravere Therapeutics, Inc.IONSn/an/an/aIONIS PHARMACEUTICALS INCTLSIn/an/an/aTriSalus Life Sciences, Inc.PTCTn/an/an/aPTC THERAPEUTICS, INC.RAPPn/an/an/aRapport Therapeutics, Inc.STIMn/an/an/aNeuronetics, Inc.NSPR−18.6%n/a−71.0%InspireMD, Inc.GHn/an/an/aGuardant Health, Inc.JUSH+29.4%n/an/aJushi Holdings Inc.ONC+4.4%+31.1%+12.6%BeOne Medicines Ltd.AHCOn/an/an/aAdaptHealth Corp.CBLLn/an/an/aCeribell, Inc.
RoseFellNo price at prices of Oct 2 How we calculate this
The four busiest stocks (most insider, Congress and fund activity) are drawn bigger. Tap a tile for the stock's page.
Biggest insider purchases
| Filed | Ticker | Insider | Type | Value | Score |
|---|---|---|---|---|---|
| Jun 15 | PBLS | Ra Capital Management, L.P.Director | ▲ BUY | $423.8M | 62 |
| Apr 20 | KLRA | Andrew T. KaplanDirector | ▲ BUY | $134.4M | 57 |
| Apr 20 | KLRA | Bain Capital Investors LLC10% owner | ▲ BUY | $134.4M | 53 |
| Mar 13 | SNDA | Michael SimanovskyDirector | ▲ BUY | $100.0M | 47 |
| Mar 2 | GENB | Noubar AfeyanDirector | ▲ BUY | $75.0M | 62 |
| Mar 2 | GENB | Noubar AfeyanDirector | ▲ BUY | $75.0M | 62 |
| May 13 | ARTV | Ra Capital Management, L.P.Director | ▲ BUY | $75.0M | 56 |
| Sep 30 | KOD | Baker Bros. Advisors LPDirector | ▲ BUY | $60.5M | 36 |
| Sep 30 | KOD | Baker Bros. Advisors LPDirector | ▲ BUY | $58.6M | 36 |
| Aug 18 | MPLT | Catalyst4, Inc.10% owner | ▲ BUY | $50.1M | 47 |
Biggest insider sales
| Filed | Ticker | Insider | Type | Value |
|---|---|---|---|---|
| Jun 1 | MDLN | Bx Mozart Ml-2 Holdco L.P.10% owner | ▼ SELL | $1.22B |
| Jun 1 | MDLN | Bcp 8 Holdings Mozart Manager LLC10% owner | ▼ SELL | $1.22B |
| Jun 1 | MDLN | Hellman & Friedman Capital Partners X (parallel), L.P.10% owner | ▼ SELL | $1.16B |
| Mar 12 | MDLN | Bx Mozart Ml-2 Holdco L.P.10% owner | ▼ SELL | $1.13B |
| Mar 12 | MDLN | Bcp 8 Holdings Mozart Manager LLC10% owner | ▼ SELL | $1.13B |
| Mar 12 | MDLN | Tc Group Cayman Investment Holdings, L.P.10% owner | ▼ SELL | $1.07B |
| Mar 12 | MDLN | Cp Circle Ml Holdco Gp, LLC10% owner | ▼ SELL | $1.07B |
| Mar 12 | MDLN | Carlyle Mozart Coinvestment Holdings, L.P.10% owner | ▼ SELL | $1.07B |
| Mar 12 | MDLN | Carlyle Group Inc.10% owner | ▼ SELL | $1.07B |
| Mar 12 | MDLN | Hellman & Friedman Capital Partners X (parallel), L.P.10% owner | ▼ SELL | $1.06B |
Latest Congress trades
| Filed | Member | Stock | Type | Amount |
|---|---|---|---|---|
| Oct 27 |  Rep. Pete SessionsR-TX-17 | ABT | ▼ SELL | $50K–$100K |
| Oct 26 | STLN | ▼ PARTIAL SELL | $1K–$15K | |
| Oct 26 | STLN | ▼ PARTIAL SELL | $1K–$15K | |
| Oct 26 | STLN | ▼ PARTIAL SELL | $15K–$50K | |
| Oct 26 | STLN | ▼ PARTIAL SELL | $15K–$50K | |
| Oct 26 | STLN | ▼ PARTIAL SELL | $15K–$50K | |
| Oct 26 | STLN | ▼ PARTIAL SELL | $1K–$15K | |
| Oct 26 | STLN | ▼ PARTIAL SELL | $1K–$15K | |
| Oct 26 | STLN | ▼ PARTIAL SELL | $15K–$50K | |
| Oct 26 | STLN | ▼ PARTIAL SELL | $15K–$50K | |
| Oct 26 | STLN | ▼ PARTIAL SELL | $15K–$50K | |
| Oct 26 | STLN | ▼ PARTIAL SELL | $1K–$15K |
New 5% stakes
- Oct 30 Hexstone Capital LLC · New 13G · 7.7% of ACTUATE THERAPEUTICS, INC.
- Oct 30 Vanguard Portfolio Management · New 13G · 5.03% of ALNYLAM PHARMACEUTICALS, INC.
- Oct 30 Vanguard Capital Management · New 13G · 5.02% of Alto Neuroscience, Inc.
- Oct 30 Vanguard Capital Management · New 13G · 5.08% of Dianthus Therapeutics, Inc. /DE/
- Oct 30 Vanguard Portfolio Management · New 13G · 5.04% of IDEXX LABORATORIES INC /DE
- Oct 30 Vanguard Capital Management · New 13G · 5.04% of Immunome Inc.
- Oct 30 Venrock Healthcare Capital Partners III, L.P. · New 13G · 11.9% of Lycia Therapeutics, Inc.
- Oct 30 Vanguard Capital Management · New 13G · 7.2% of MEDICINOVA INC
Compare health care stocks
Examples
- Of the health care stocks on this site, AVITA Medical, Inc. (RCEL) rose the most over three months (+198.2%).
- The largest open-market purchase in the sector in the past year: Ra Capital Management, L.P. (Director) bought $423.8M of PBLS, filed Jun 15.
Other sectors
TechnologyFinancialsConsumer DiscretionaryConsumer StaplesIndustrialsEnergyMaterialsUtilitiesReal EstateCommunication Services
WallStPal · PDF guide
About this page
WallStPal explains public SEC filings and congressional stock trade reports in plain English. Nothing is for sale; the site is free and supported by ads.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- 13F
- A quarterly list of U.S. stocks held by an investment manager with more than $100 million, filed within 45 days after each quarter ends.
- STOCK Act
- A 2012 law that requires members of Congress to report stock trades by themselves, a spouse or a dependent child within 45 days.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
We read the long, boring forms that grown-ups file with the government and tell you what they say in normal words.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.